Shionogi Of Japan Plans To Apply For Approval Of New Flu Antiviral
This article was originally published in PharmAsia News
Executive Summary
Japan's Shionogi expects its peramivir drug to compete with the two most popular anti-flu drugs to reach the Japanese market as early as October 2010